Goldman Sachs’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Buy |
334,953
+147,026
| +78% | +$122K | ﹤0.01% | 4561 |
|
|
2025
Q1 | $126K | Sell |
187,927
-156,931
| -46% | -$106K | ﹤0.01% | 4774 |
|
|
2024
Q4 | $326K | Buy |
344,858
+95,730
| +38% | +$90.4K | ﹤0.01% | 4500 |
|
|
2024
Q3 | $379K | Buy |
249,128
+146,463
| +143% | +$223K | ﹤0.01% | 4249 |
|
|
2024
Q2 | $122K | Sell |
102,665
-525,889
| -84% | -$626K | ﹤0.01% | 4478 |
|
|
2024
Q1 | $1.13M | Buy |
+628,554
| New | +$1.13M | ﹤0.01% | 3539 |
|
|
2022
Q3 | – | Sell |
-64,273
| Closed | -$70K | – | 5472 |
|
|
2022
Q2 | $70K | Sell |
64,273
-38,048
| -37% | -$41.4K | ﹤0.01% | 5208 |
|
|
2022
Q1 | $128K | Sell |
102,321
-157,535
| -61% | -$197K | ﹤0.01% | 5233 |
|
|
2021
Q4 | $416K | Buy |
259,856
+52,287
| +25% | +$83.7K | ﹤0.01% | 4613 |
|
|
2021
Q3 | $676K | Buy |
207,569
+157,562
| +315% | +$513K | ﹤0.01% | 4218 |
|
|
2021
Q2 | $316K | Sell |
50,007
-13,763
| -22% | -$87K | ﹤0.01% | 4675 |
|
|
2021
Q1 | $135K | Buy |
+63,770
| New | +$135K | ﹤0.01% | 4956 |
|
|
2020
Q4 | – | Sell |
-21,304
| Closed | -$52K | – | 4636 |
|
|
2020
Q3 | $52K | Buy |
+21,304
| New | +$52K | ﹤0.01% | 4324 |
|
|
2016
Q3 | – | Sell |
-232
| Closed | -$12K | – | 4534 |
|
|
2016
Q2 | $12K | Buy |
+232
| New | +$12K | ﹤0.01% | 4452 |
|
|
2016
Q1 | – | Sell |
-198
| Closed | -$11K | – | 4484 |
|
|
2015
Q4 | $11K | Buy |
198
+21
| +12% | +$1.17K | ﹤0.01% | 4400 |
|
|
2015
Q3 | $24K | Buy |
+177
| New | +$24K | ﹤0.01% | 4438 |
|
|
2015
Q1 | – | Sell |
-149
| Closed | -$38K | – | 4477 |
|
|
2014
Q4 | $38K | Sell |
149
-206
| -58% | -$52.5K | ﹤0.01% | 4421 |
|
|
2014
Q3 | $86K | Buy |
355
+201
| +131% | +$48.7K | ﹤0.01% | 4265 |
|
|
2014
Q2 | $47K | Sell |
154
-69
| -31% | -$21.1K | ﹤0.01% | 4293 |
|
|
2014
Q1 | $68K | Buy |
223
+27
| +14% | +$8.23K | ﹤0.01% | 4196 |
|
|
2013
Q4 | $82K | Buy |
196
+7
| +4% | +$2.93K | ﹤0.01% | 4121 |
|
|
2013
Q3 | $191K | Buy |
+189
| New | +$191K | ﹤0.01% | 3857 |
|